A Pragmatic Trial on Actions For Collaborative Community Engaged Strategies for HPV

NARecruitingINTERVENTIONAL
Enrollment

1,854

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 30, 2026

Conditions
HPV
Interventions
BEHAVIORAL

Baseline Assessment For Mother-Daughter Day HPV Campaign

"Pre-Implementation:~Identify, screen, and enroll mother-daughter dyads in the study to participate in the upcoming Mother-Daughter Day event on HPV vaccination and screening.~Complete baseline surveys with enrolled participants. Distribute reminder cards and send text messages to mother-daughter dyads who agree to participate in the mother-daughter day campaign."

BEHAVIORAL

Implement Mother-Daugther Day HPV Campaign

"Tailor and adapt to context: Mother-Daughter Day campaigns will be tailored and adapted to the local contexts within the 18 LGA.~Trained community health workers will implement the tailored Mother-Daughter Campaign by providing education on cervical cancer control and educational materials on HPV vaccination and HPV screening.~Engage mothers and daughters with on-site access to services: This includes offer of onsite vaccinations to girls by study nurse as well as offer of onsite self-collection screening kits to mothers and caregivers in a private area, along with instructions on how to use and return the sample.~Distribute gift bags with HPV vaccination cards, follow-up reminders, and linkage cards for participants with positive test results, as community health workers continue to provide onsite support and assistance."

BEHAVIORAL

Post-Implementation Follow-Up

"A follow-up invitation will be sent to participate in a consultative phone call with study health workers to review self-collection results.~Participants with positive HPV test results will be linked to follow-up care and treatment."

Trial Locations (1)

Unknown

RECRUITING

Nigerian Institute of Medical Research, Yaba

All Listed Sponsors
collaborator

Nigerian Institute of Medical Research

OTHER_GOV

collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Washington University School of Medicine

OTHER